Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Trade secrets are a cornerstone in the strategic architecture of businesses, representing invaluable assets that give it a competitive edge. These could encompass formulas, practices, processes, ...